Skip to content

A safety study of skin care products containing Bioceramide in atopic dermatitis patients

A safety study of skin care products containing Bioceramide in atopic dermatitis patients - A safety study of skin care products containing Bioceramide in atopic dermatitis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000022638
Enrollment
35
Registered
2016-06-08
Start date
2016-06-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis

Interventions

Skin care products containing Bioceramide (cleanser, skin toner and moisturizing gel) are applied twice a day for 28 days

Sponsors

Zenyaku Kogyo Co., LTD,
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Atopic dermatitis patients; 1)with slight severity condition, 2)who are no need for treatment by steroidal and immunosuppressant drugs, 3)who are Japanese females and males between 20 years to 54 years old, and 4)who understand in detail and have written consent for the study protocol.

Exclusion criteria

Exclusion criteria: 1)Patients with an evidence of skin inflammation caused by atopic dermatitis or with the other skin disease that would interfere with clinical evaluation 2)Patients with any known allergies and hypersensitivity to any of the ingredients of the test products 3)Patients with underlying disease who need a admission to a hospital 4)Patients taking steroidal or immunosuppressant drugs for atopic dermatitis 5)Patients with history of participation in another clinical study within six (6) months 6)Women who are pregnant or breastfeeding, and women of reproductive potential who are not willing to use adequate contraception during study 7)Patients who are not willing to observe the limitation or prohibit matters 8)Patients who are judged inappropriate to participate by investigators.

Design outcomes

Primary

MeasureTime frame
To evaluate the safety of skin care products containing Bioceramide based upon 1) frequency, types and severity of adverse events, and 2) results of safety assessments by dermatologists

Secondary

MeasureTime frame
To evaluate the efficacy of skin care products containing Bioceramide based upon dermatological assessments, itch score, skin hydration and improvement grade of symptom

Countries

Japan

Contacts

Public ContactMikiko Tanaka

Japan Aesthetic Dermatology Symposium Secretariat

m.tanaka@jp-ads.com045-682-4114

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026